Company intelligence / Profile preview

Dynamic Biosensors

Munich, Bavaria, Germany

Ownership: Private
Employees: ~60
Development stage: Other

Overview

Dynamic Biosensors develops and supplies advanced biosensor instruments and consumables for detailed biophysical analysis of molecular interactions, supporting drug discovery, cell & gene therapy research, and molecular biology. Its core technologies include switchSENSE, heliX, heliXcyto, and single-cell Interaction Cytometry (scIC). The company was acquired by Bruker on October 2, 2024.

Industry: Drug Discovery Services

Partnerships

2bind (CRO technology/service partnership)

Beyond the preview

Go deeper on Dynamic Biosensors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dynamic Biosensors.

Explore the full profile